Last C$9.68 CAD
Change Today +0.18 / 1.89%
Volume 5.2K
RX On Other Exchanges
Symbol
Exchange
OTC US
Venture
As of 3:54 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for biosyent inc (RX)

Year over year, BioSyent Inc. has been able to grow revenues from $4.3M USD to $6.7M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 51.38% to 47.17%. This was a driver that led to a bottom line growth from $1.3M USD to $1.7M USD.
View Income Statement In Canadian Dollar
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
USD
Dec 31
2011
Restated
USD
Dec 31
2012
USD
Dec 31
2013
USD
4 Year
Trend
Revenues1.42.44.36.7
TOTAL REVENUES1.42.44.36.7
Cost of Goods Sold0.40.50.91.4
GROSS PROFIT1.11.93.45.3
Selling General & Admin Expenses, Total0.91.52.23.2
R&D Expenses--0.00.00.0
Depreciation & Amortization, Total0.0------
OTHER OPERATING EXPENSES, TOTAL1.01.52.23.2
OPERATING INCOME0.10.41.22.1
Interest and Investment Income--0.00.00.0
NET INTEREST EXPENSE--0.00.00.0
Currency Exchange Gains (Loss)0.0------
Other Non-Operating Income (Expenses)0.0------
EBT, EXCLUDING UNUSUAL ITEMS0.10.41.22.1
Other Unusual Items, Total-0.1------
Other Unusual Items-0.1------
EBT, INCLUDING UNUSUAL ITEMS0.00.41.22.1
Income Tax Expense-----0.10.5
Earnings from Continuing Operations0.00.41.31.7
NET INCOME0.00.41.31.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS0.00.41.31.7
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS0.00.41.31.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RX:CN C$9.68 CAD +0.18

RX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RX.
View Industry Companies
 

Industry Analysis

RX

Industry Average

Valuation RX Industry Range
Price/Earnings 45.2x
Price/Sales 11.2x
Price/Book 17.2x
Price/Cash Flow 43.1x
TEV/Sales 10.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOSYENT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.